A research team performed a large-scale genome analysis of Japanese and European populations and discovered gene regions (genetic polymorphisms) related to allergic sensitization. Some of these ...

Technoderma Medicines has completed its phase 2a trial of TDM-180935 for the treatment of atopic dermatitis, demonstrating the efficacy of the ointment’s 2% formulation, the company announced in ...

WOMEN'S HISTORY MONTH: March is Women's History Month, when the often-overlooked achievements of women, and women who have fought for their right to be recognised, are celebrated. We've rounded up ...

Dermatitis refers to skin inflammation. Types include atopic dermatitis (eczema), contact dermatitis, seborrheic dermatitis, and dishydrotic dermatitis. Symptoms may include dry skin, itchiness ...

Perspective from Benjamin Ungar, MD Severe disease, male sex, family history and prenatal factors were significantly associated with an increased risk for atopic march progression in infants with ...

HELSINKI — New Long March rockets and commercially-developed launch vehicles are expected to have their first flights in 2025, boosting China’s overall launch capabilities. The various ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Viewed from the C-suite, there is a lot to like. Human robots do not get sick, require pensions or join ...

Thousands of Bangladeshis rallied at a ‘March for Unity’ in the capital Dhaka on Tuesday to mark the student-led uprising five months ago that led to the ouster of longstanding Prime Minister ...

The Anti-Discrimination Student Movement organised what it called the March for Unity on Tuesday at the Central Shaheed Minar, a national monument in Dhaka. Protesters chanted slogans calling for ...

DHAKA, Dec 31 (Reuters) - Thousands of Bangladeshis rallied at a 'March for Unity' in the capital Dhaka on Tuesday to mark the student-led uprising five months ago that led to the ouster of ...

The CHMP has recommended nemolizumab’s approval for subcutaneous use for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older who are candidates for systemic ...